NC
Neelam Chopra
About Neelam Chopra
Data last updated:
Neelam Chopra has 11 years in corporate governance. Holds Director role. Currently with 2 companies, including S&N Shreefal Confectioners Private Limited and Lunaris Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is S&N Shreefal Confectioners Private Limited at ₹46.13 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Mar 2015 | 2013 | ₹46.13 Cr (FY 2025) | Active | |
| Director | 16 Jul 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neelam Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neelam Chopra
Neelam Chopra has 11 years in corporate governance. Holds Director role. Currently with 2 companies, including S&N Shreefal Confectioners Private Limited and Lunaris Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is S&N Shreefal Confectioners Private Limited at ₹46.13 Cr (FY 2025).
Neelam Chopra is associated with 2 companies as Director, including S&N Shreefal Confectioners Private Limited (₹46.13 Cr), Lunaris Lifesciences Private Limited.
Neelam Chopra has expertise in General Business.
Neelam Chopra has 11 years in corporate governance.
By reported revenue, the largest current company of Neelam Chopra is S&N Shreefal Confectioners Private Limited, with revenue of ₹46.13 Cr (FY 2025).
Neelam Chopra currently holds positions at 2 companies: S&N Shreefal Confectioners Private Limited (₹46.13 Cr), Lunaris Lifesciences Private Limited.